Lingling Ren
Impact in
- Pharmaceutical Science top 10%
- Advancements in Transdermal Drug Delivery
-
- Immune cells in cancer
- Immunotherapy and Immune Responses
Papers in
-
- Nanoplatforms for cancer theranostics 3
- Surgery 2
- Intestinal and Peritoneal Adhesions 2
- Surgical Sutures and Adhesives 2
- Hernia repair and management 2
- Co-authors
- Chunshun Zhao (7 shared papers)Yanjuan Huang (6 shared papers)Jingwen Jiang (5 shared papers)Zilin Guan (5 shared papers)Xiaoyu Xu (2 shared papers)Zeqian Huang (2 shared papers)Yong Luo (3 shared papers)Yali Jiang (1 shared paper)
In The Last Decade
Lingling Ren
11 papers receiving 326 citations
Lingling Ren's Hit Papers
Peers
Comparison fields: 5 of 67
- Pharmaceutical Science 30
- Immunology 75
- Biomaterials 49
- Molecular Medicine 15
- Biomedical Engineering 135
Countries citing papers authored by Lingling Ren
This map shows the geographic impact of Lingling Ren's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lingling Ren with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lingling Ren more than expected).
Fields of papers citing papers by Lingling Ren
This network shows the impact of papers produced by Lingling Ren. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lingling Ren. The network helps show where Lingling Ren may publish in the future.
Co-authors
The 25 scholars most cited alongside Lingling Ren, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 148 | |
| 2 | 2021 | 43 | |
| 3 | A ROS-responsive and scavenging hydrogel for postoperative abdominal adhesion prevention Hit paper breakdown → | 2024 | 40 |
| 4 | 2022 | 39 | |
| 5 | 2024 | 23 | |
| 6 | 2022 | 17 | |
| 7 | 2009 | 7 | |
| 8 | 2022 | 5 | |
| 9 | 2014 | 4 | |
| 10 | 2025 | 1 | |
| 11 | 2025 | 1 | |
| 12 | 2025 | 0 | |
| 13 | 2025 | 0 |
About Lingling Ren
Lingling Ren is a scholar working on Biomedical Engineering, Surgery, Molecular Biology, Pulmonary and Respiratory Medicine and Oncology, having authored 13 papers that have together received 328 indexed citations. Recurring topics across this work include Nanoplatforms for cancer theranostics (3 papers), Intestinal and Peritoneal Adhesions (2 papers), Surgical Sutures and Adhesives (2 papers), Hernia repair and management (2 papers), Ferroptosis and cancer prognosis (1 paper), Photodynamic Therapy Research Studies (1 paper), Inflammatory mediators and NSAID effects (1 paper) and Peptidase Inhibition and Analysis (1 paper). The work is most often cited by research in Pharmaceutical Science (30 citations), Immunology (75 citations), Biomaterials (49 citations), Molecular Medicine (15 citations) and Biomedical Engineering (135 citations). Lingling Ren has collaborated with scholars based in China, Sri Lanka and Australia. Frequent co-authors include Chunshun Zhao, Yanjuan Huang, Jingwen Jiang, Zilin Guan, Xiaoyu Xu, Zeqian Huang, Yong Luo, Yali Jiang, Yifeng Shen and Meixu Chen. Their work appears in journals such as Journal of Controlled Release, Nature Communications, Journal of Medicinal Chemistry, Frontiers in Oncology and Separation and Purification Technology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.